Correlation Between Enfusion and ANSYS
Can any of the company-specific risk be diversified away by investing in both Enfusion and ANSYS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enfusion and ANSYS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enfusion and ANSYS Inc, you can compare the effects of market volatilities on Enfusion and ANSYS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enfusion with a short position of ANSYS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enfusion and ANSYS.
Diversification Opportunities for Enfusion and ANSYS
Very poor diversification
The 3 months correlation between Enfusion and ANSYS is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Enfusion and ANSYS Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ANSYS Inc and Enfusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enfusion are associated (or correlated) with ANSYS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ANSYS Inc has no effect on the direction of Enfusion i.e., Enfusion and ANSYS go up and down completely randomly.
Pair Corralation between Enfusion and ANSYS
Given the investment horizon of 90 days Enfusion is expected to generate 1.27 times more return on investment than ANSYS. However, Enfusion is 1.27 times more volatile than ANSYS Inc. It trades about 0.17 of its potential returns per unit of risk. ANSYS Inc is currently generating about 0.14 per unit of risk. If you would invest 806.00 in Enfusion on September 2, 2024 and sell it today you would earn a total of 188.00 from holding Enfusion or generate 23.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Enfusion vs. ANSYS Inc
Performance |
Timeline |
Enfusion |
ANSYS Inc |
Enfusion and ANSYS Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Enfusion and ANSYS
The main advantage of trading using opposite Enfusion and ANSYS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enfusion position performs unexpectedly, ANSYS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANSYS will offset losses from the drop in ANSYS's long position.Enfusion vs. ON24 Inc | Enfusion vs. Paycor HCM | Enfusion vs. E2open Parent Holdings | Enfusion vs. Braze Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |